title: Inhibition of thrombocyte aggregation during extracorporeal lung assist: a case report.
abstract: In extracorporeal lung assist, membrane oxygenators are used to improve gas exchange. Accumulations on the membranes of coagulation end products can increase resistance to blood flow and diffusion distance. Thus, functioning of the system can be impaired and, in extreme cases, lead to malfunction which may necessitate change out of the oxygenator. We describe a method that complements conventional continuous heparinisation with the administration of acetylsalicylic acid to inhibit thrombocyte aggregation.
authors.affiliation: Department of Cardiothoracic Surgery, University Hospital of Regensburg, Regensburg, Germany. Alois.Philipp@Klinik.uni-regensburg.de
authors.forename: Alois
authors.initials: A
authors.lastname: Philipp
authors.forename: Thomas
authors.initials: T
authors.lastname: Müller
authors.forename: Thomas
authors.initials: T
authors.lastname: Bein
authors.forename: Maik
authors.initials: M
authors.lastname: Foltan
authors.forename: Franz-Xaver
authors.initials: FX
authors.lastname: Schmid
authors.forename: Dietrich
authors.initials: D
authors.lastname: Birnbaum
authors.forename: Christof
authors.initials: C
authors.lastname: Schmid
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D008171:Lung Diseases / Q000628:therapy*; D010107:Oxygenators, Membrane; D010974:Platelet Aggregation; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin